Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 21, 2025
Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencingSumiko Ohnami, Keiichi Hatakeyama, Takeshi Nagashima, et al.
Human Genome Variation|September 30, 2021
JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencingMasakuni Serizawa, Maki Mizuguchi, Kenichi Urakami, et al.
BMC Cancer|February 20, 2021
Mutational concordance analysis provides supportive information for double cancer diagnosisKeiichi Hatakeyama, Takeshi Nagashima, Akifumi Notsu, et al.
Scientific Reports|June 13, 2024
Tumor cell enrichment by tissue suspension improves sensitivity to copy number variation in diffuse gastric cancer with low tumor contentKeiichi Hatakeyama, Koji Muramatsu, Takeshi Nagashima, et al.
Scientific Reports|April 6, 2017
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumorsKeiichi Ohshima, Keiichi Hatakeyama, Takeshi Nagashima, et al.
NPJ Precision Oncology|January 22, 2026
Translating spatial transcriptomic signatures in adenosquamous carcinoma into bulk prognostic biomarkers in lung adenocarcinoma: a bottom-up approachKeiichi Hatakeyama, Takuya Kawata, Koji Muramatsu, et al.
Biomedical Research (Tokyo, Japan)|August 21, 2022
Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patientsYuji Shimoda, Takeshi Nagashima, Kenichi Urakami, et al.
Scientific Reports|October 26, 2022
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genesSumiko Ohnami, Akane Naruoka, Mitsuhiro Isaka, et al.
Gastroenterology|June 3, 2008
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer riskShumpei Ohnami, Yasunori Sato, Kimio Yoshimura, et al.
Molecular and Cellular Biochemistry|May 13, 2021
BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancerShumpei Ohnami, Kouji Maruyama, Kai Chen, et al.
Pageof 5